Disseminating NIH Evidence Based Sickle Cell Recommendations in North Carolina

在北卡罗来纳州传播 NIH 基于证据的镰状细胞建议

• 批准号: 9208079
• 负责人: Paula Tanabe
• 金额: $ 39.99万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-09-30 至 2020-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9208079
• 关键词: Disseminating; NIH; Evidence; Based; Sickle

Abstract This project will improve the efficiency and quality of healthcare for persons with sickle cell disease, an under-served and at risk population by implementing a co-management model of care. Many patients with sickle cell disease (SCD) receive care primarily from specialty physicians and emergency departments (ED), thus resulting in a lack of primary care and a high number of ED visits and hospitalizations. Study team members will disseminate a toolbox of decision support tools, based upon the National Heart, Lung and Blood Institute (NHLBI) published “Evidence-Based Management of Sickle Cell Disease: Expert Panel Report, 2014”, to primary care and emergency department providers in North Carolina and portions of South Carolina. The goal is to improve PCP and SCD specialist co-management. We will survey providers about their perception of the awareness, use and acceptability of the tools. We will survey patients about the awareness and acceptability of the co-management model. We will also conduct an exploratory cost analysis. The overall purpose of this demonstration and dissemination project is to evaluate patient and system outcomes associated with the dissemination of a toolbox of decision support tools to PCP’s and ED providers across NC and SC. The specific aims of the project are to: 1. Examine the effects of the decision support tools on study outcomes [ED visits, hospitalization, re-hospitalization within 30 days, PCP and/or SCD specialty visits, co- management, and HU prescription fills] during the 12 months prior to project start and across the 3.5 years of the project in NC and SC. 1.1. Determine which patient (age, gender, rural residence) and practice level (specific CCNC networks, specific PCP practices) characteristics, and receipt of the dissemination tools) predict study outcomes. 2. Evaluate individual provider-reported awareness, acceptability, and provider-reported use of each of the health maintenance tables and algorithms in the toolbox amongst PCPs, SCD specialists, and ED providers in NC and SC at project start and yearly across the project. 2.1. Explore patient-reported awareness and acceptability of a co-management model of care in NC and SC. 3. Conduct an exploratory cost analysis of the dissemination and implementation of the SCD co- management model and its effect on healthcare resource utilization.

抽象的 该项目将提高镰状细胞患者的医疗保健效率和质量 通过实施共同管理模型，疾病，服务不足和处于风险的人群 关心。许多镰状细胞疾病（SCD）的患者从专业中获得护理小学 医师和急诊科（ED），因此导致缺乏初级保健和高度 ED访问和住院数量。学习团队成员将传播一个工具箱 基于国家心脏，肺和血液研究所（NHLBI）的决策支持工具 发表的“基于证据的镰状细胞疾病管理：2014年专家小组报告”， 北卡罗来纳州的初级保健和急诊部提供商和南部的部分 卡罗来纳州。目的是改善PCP和SCD专家共同管理。我们将调查 提供者关于他们对工具的意识，使用和可接受性的看法。我们将 调查患者有关共同管理模型的意识和可接受性。我们将 还进行探索性成本分析。这次演示的总体目的和 传播项目是为了评估患者和与 向北卡罗来纳州PCP和ED提供商传播决策支持工具的工具箱 sc。该项目的具体目的是： 1。检查决策支持工具对研究结果的影响[ED访问， 住院，30天内的重新住院，PCP和/或SCD专业访问，共同 管理和HU处方填充]在项目开始之前的12个月中 该项目在NC和SC的3。5年。 1.1。确定哪个患者（年龄，性别，农村住所）和练习水平（特定CCNC 网络，特定的PCP实践）特征和传播工具的接收） 预测研究结果。 2。评估个人提供者报告的意识，可接受性和提供者报告的使用 PCPS的工具箱中的每个健康维护表和算法的SCD NC和SC的ED提供商在项目开始和每年的项目开始。 2.1。探索患者报告的意识和可接受性的共同管理模型 在NC和SC的护理。 3.对SCD共同的传播和实施进行探索性成本分析 管理模型及其对医疗资源利用的影响。